Search Results - Ferrer-Donato, Águeda

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone

    Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone by Díaz-García, Diana, Ferrer-Donato, Águeda, Méndez-Arriaga, José M., Cabrera-Pinto, Marta, Díaz-Sánchez, Miguel, Prashar, Sanjiv, Fernandez-Martos, Carmen M., Gómez-Ruiz, Santiago

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Methodology Aspects of Colony Maintain for a Murine Model of Amyotrophic Lateral Sclerosis (ALS) TDP-43 Proteinopathy

    Methodology Aspects of Colony Maintain for a Murine Model of Amyotrophic Lateral Sclerosis (ALS) TDP-43 Proteinopathy by Álvaro-Alonso, César, Ferrer-Donato, Águeda, Fernández-Torres, Elizabeth, Carballo-Villa, Mónica, Fernandez-Martos, Carmen M

    Published in Animals (Basel)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)

    Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS) by Ferrer-Donato, Agueda, Contreras, Ana, Frago, Laura M., Chowen, Julie A., Fernandez-Martos, Carmen M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)

    The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS) by Ferrer‐Donato, Agueda, Contreras, Ana, Fernandez, Paloma, Fernandez‐Martos, Carmen M.

    Published in Brain and behavior
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Early treatment with UR13870, a novel inhibitor of p38α mitogenous activated protein kinase, prevents hyperreflexia and anxiety behaviors, in the spared nerve injury model of neuropathic pain

    Early treatment with UR13870, a novel inhibitor of p38α mitogenous activated protein kinase, prevents hyperreflexia and anxiety behaviors, in the spared nerve injury model of neuro... by Galan-Arriero, Iriana, Avila-Martin, Gerardo, Ferrer-Donato, Agueda, Gomez-Soriano, Julio, Piazza, Stefano, Taylor, Julian

    Published in Neuroscience letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: